Anti-HIV-1 activities and pharmacokinetics of new arylpiperazinyl fluoroquinolones
- PMID: 11858992
- DOI: 10.1016/s0960-894x(02)00003-3
Anti-HIV-1 activities and pharmacokinetics of new arylpiperazinyl fluoroquinolones
Abstract
Anti-HIV-1 activities and pharmacokinetics of a series of novel arylpiperazinyl fluoroquinolones are reported. Modification at the C-8 position with a trifluoromethyl group was superior to that with a difluoromethoxy group to achieve higher anti-HIV-1 activity. Two compounds studied exhibited quite high anti-HIV-1 activities (IC(50)<50 nM) in vitro and high bioavailabilities (BA>90%) in monkeys.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical